Valuation: Medicure Inc.

Market Cap 13.46M 9.49M 8.29M 7.62M 7.1M 903M 13.69M 91.69M 35.53M 443M 35.63M 34.86M 1.53B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.52M 7.42M 6.48M 5.95M 5.55M 706M 10.7M 71.64M 27.76M 346M 27.84M 27.24M 1.19B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.78%
1 week+0.78%
1 month+11.21%
3 months+15.18%
6 months+13.16%
Current year+13.16%
1 week 1.28
Extreme 1.28
1.29
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 92 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Chief Executive Officer

1,000 0.0096%
06-22Buy

Chief Executive Officer

200 0.0019%
06-22Buy

Chief Executive Officer

2,500 0.0240%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+0.78%+3.20%+10.26% 9.48M
+3.98%+10.23%+73.54%+132.19% 56.21B
-3.12%+5.11%+71.57%+94.67% 55.38B
+3.86%+8.13%-9.27%-9.62% 23.75B
+4.30%+7.87%+14.32%+428.91% 23.19B
+3.64%+10.54%+39.81%-4.50% 18.14B
+4.11%+9.85%+42.56%-27.36% 16.84B
+2.57%+20.26%+181.98%+355.99% 15.86B
+3.50%+5.64%+28.04%+192.26% 13.56B
+7.20%+10.70%+42.91% - 12.97B
Average +3.13%+6.84%+48.87%+130.31% 23.59B
Weighted average by Cap. +2.42%+6.09%+57.10%+135.02%

Financials

2024 2025
Net sales 21.91M 15.44M 13.49M 12.39M 11.56M 1.47B 22.28M 149M 57.82M 721M 57.99M 56.73M 2.48B 28.86M 20.34M 17.77M 16.32M 15.22M 1.94B 29.34M 197M 76.16M 950M 76.38M 74.72M 3.27B
Net income -1.04M -732K -640K -588K -548K -69.73M -1.06M -7.08M -2.74M -34.2M -2.75M -2.69M -118M -7.1M -5M -4.37M -4.01M -3.74M -476M -7.22M -48.33M -18.73M -234M -18.79M -18.38M -805M
Net Debt -6.32M -4.45M -3.89M -3.57M -3.33M -424M -6.42M -43.02M -16.67M -208M -16.72M -16.36M -716M -2.94M -2.08M -1.81M -1.67M -1.55M -198M -2.99M -20.05M -7.77M -96.91M -7.79M -7.62M -334M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
30/06/26 CA$1.290 +0.78% 1,140
24/06/26 CA$1.280 +2.40% 550